Kathleen England is a Senior Advisor for Laboratories at KNCV. She has worked in TB laboratory development and diagnostic implementation for the past 5 years in several Asian and African countries. Prior to this experience, Kathleen was involved in Tuberculosis Research which includes biomarker studies, clinical trials and drug development studies in vitro and in vivo. Further she has been involved in implementation strategies for GeneXpert as well as various laboratory capacity building and programmatic diagnostic developments. She has additional experience in laboratory accreditation and implementing quality diagnostic services in TB control programs. In 2014, Kathleen joined KNCV TB foundation, The Hague, The Netherlands where her responsibilities involve not only laboratory technical assistance, but oversight and program management activities for over 20 country laboratory programs supported by USAID.

Her position involves remote support to all countries and country monitoring missions to observe activities and assess program developments. Further, Kathleen is a supportive member of the STOP TB partners Global Laboratory Initiatives program with WHO in which she participates in monthly meetings and expert panels which develops global guidance and recommendations on polices for TB diagnosis and diagnostic strategies to support HBDC TB control programs. Prior to working at KNCV, Kathleen worked in programs to assist the TB programs for North Korea under Stanford University (20011-2013) and Mongolia (2011) under Mèdecins Sans Frontières. Her research experience was based at NIH, NIAID under the TBRS program (2009-2011) which provided her clinical trial experience in both South Korea and China, animal model anti-TB drug efficacy studies, in vitro antimicrobial assays, and pharmacokinetic studies.